Status:
COMPLETED
Prevention of Persistent Opioid Use in Mothers
Lead Sponsor:
Stanford University
Conditions:
Opioid Use
Postpartum Disorder
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Our previous work has identified the group of women at risk for prolonged pain, opioid use and poor functional recovery after childbirth. The optimal intervention to mitigate this risk is unknown. We ...
Detailed Description
A small percent of the large population of women who give birth have difficulty with prolonged pain, opioid use and poor functional recovery. This may be the first opiate exposure and significant heal...
Eligibility Criteria
Inclusion
- Delivery within 5 days, able to provide informed consent, English speaker
Exclusion
- Opiate use disorder
Key Trial Info
Start Date :
September 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2021
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT03472521
Start Date
September 17 2018
End Date
April 10 2021
Last Update
May 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lucille Packard Children's Hospital
Palo Alto, California, United States, 94305